Email This Article
Headlines & Perspectives
Amag Soars as FDA Plans Quick Drug Review
By
Elizabeth Trotta
11/13/08 - 10:45 AM EST
The stock jumps 70% after the Food and Drug Administration says it will give a speedy review to the company's latest submission for an iron-replacement therapy.
TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,847.06 | 1,347.94 | 2,921.62 | 19.64 |
Oil *
118.12
|
|
UP
45.83 |
UP
5.30 |
UP
17.74 |
DOWN
0.05 |
10 Yr
1.96%
SPDR Gold
167.66
|
|
+0.36%
|
+0.39%
|
+0.61%
|
-0.25%
|
Data delayed 20 minutes |
Connect with TheStreet